369 related articles for article (PubMed ID: 10405926)
1. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis.
Miyata M; Sato Y; Kasukawa R
J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid factors from patients with rheumatoid arthritis react with beta 2-microglobulin.
Williams RC; Malone CC; Tsuchiya N
J Immunol; 1992 Aug; 149(3):1104-13. PubMed ID: 1378864
[TBL] [Abstract][Full Text] [Related]
3. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
Robbins DL; Wistar R
J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
[TBL] [Abstract][Full Text] [Related]
4. Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis.
Milosević-Jovcić N; Cirić D; Hajduković-Dragojlović L; Mircetić V
Rheumatology (Oxford); 2004 Sep; 43(9):1190-3. PubMed ID: 15238645
[TBL] [Abstract][Full Text] [Related]
5. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
[TBL] [Abstract][Full Text] [Related]
6. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis.
Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL
J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795
[TBL] [Abstract][Full Text] [Related]
7. The subclass distribution of human IgG rheumatoid factor.
Cohen PL; Cheek RL; Hadler JA; Yount WJ; Eisenberg RA
J Immunol; 1987 Sep; 139(5):1466-71. PubMed ID: 3624864
[TBL] [Abstract][Full Text] [Related]
8. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
Swedler W; Wallman J; Froelich CJ; Teodorescu M
J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
[TBL] [Abstract][Full Text] [Related]
9. Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.
Tarkowski A; Nilsson LA
J Clin Lab Immunol; 1983 Nov; 12(3):129-35. PubMed ID: 6663605
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid factors of immunoglobulin classes IgA, IgG and IgM: methods of determination and clinical value].
Hermann E; Vogt P; Müller W
Schweiz Med Wochenschr; 1986 Sep; 116(38):1290-7. PubMed ID: 3775335
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis.
Houssien DA; Jonsson T; Davies E; Scott DL
J Rheumatol; 1997 Nov; 24(11):2119-22. PubMed ID: 9375869
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
14. [IgG RF analysis of supernatant of cultured synovia in patients with rheumatoid arthritis].
Yu M; Zhang C; Shi L; Shan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):151-4. PubMed ID: 7656398
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
18. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
19. Which antigen to use in the detection of rheumatoid factors? Comparison of patients with rheumatoid arthritis and subjects with 'false positive' rheumatoid factor reactions.
Tuomi T
Clin Exp Immunol; 1989 Sep; 77(3):349-55. PubMed ID: 2805406
[TBL] [Abstract][Full Text] [Related]
20. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
